Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2019

01-01-2019 | Original Article

Performance of rapid antimicrobial susceptibility testing by disk diffusion on MHR-SIR agar directly on urine specimens

Authors: Claire Périllaud-Dubois, Benoît Pilmis, Julien Diep, Gauthier Péan de Ponfilly, Simon Perreau, Louise Ruffier d’Epenoux, Assaf Mizrahi, Carine Couzigou, Barbara Vidal, Alban Le Monnier, Jean-Claude Nguyen Van

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2019

Login to get access

Abstract

The standard method for the diagnosis of urinary tract infections is urine culture that requires 18–48 h for the identification of the bacteria and an additional 24 h until the results of antimicrobial susceptibility testing (AST) are available. We evaluated here a rapid AST method by disc diffusion performed directly on urine samples with a delay of 8 h. A total of 245 urine samples with monobacterial Gram negative observed on microscopy were tested in parallel by two AST methods. Rapid AST method was performed directly on urine samples using Rapid Mueller-Hinton (MHR-SIR) with 8-h incubation before reading and standard method was performed as usual. We compared the categorical agreement and the correlation between the diameters obtained by standard method and by MHR-SIR directly on urine samples. Over the 5285 tested combinations, we observed 5172 (97.9%) categorical agreement, 82 (1.5%) minor errors, 17 (0.3%) major errors, and 14 (0.3%) very major errors. Our results showed an excellent categorical agreement and correlations between diameters for MHR-SIR and standard methods. MHR-SIR performed directly on urine samples with monomicrobial Enterobacteriacae can predict the result of overall AST profile in 8 h with reliable results. The main advantage of MHR-SIR is that it offers the possibility of obtaining results 40 h earlier than conventional AST. The cost is estimated for less than 6 USD for 16 antibiotics, chosen by the microbiologist.
Appendix
Available only for authorised users
Literature
2.
go back to reference Caron F et al (2018) Practice guidelines for the management of adult community-acquired urinary tract infections. Méd Mal Infect 48(5):327–358 Caron F et al (2018) Practice guidelines for the management of adult community-acquired urinary tract infections. Méd Mal Infect 48(5):327–358
3.
go back to reference Laxminarayan R et al (2013) Antibiotic resistance—the need for global solutions. Lancet Infect Dis 13(12):1057–1098 Laxminarayan R et al (2013) Antibiotic resistance—the need for global solutions. Lancet Infect Dis 13(12):1057–1098
4.
go back to reference ECDC (2016) Antimicrobial resistance surveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) ECDC (2016) Antimicrobial resistance surveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
5.
go back to reference Observatoire National de l’Epidémiologie de la Résistance Bactérienne aux Antibiotiques (ONERBA) (2015) Rapport d’activité annuel Observatoire National de l’Epidémiologie de la Résistance Bactérienne aux Antibiotiques (ONERBA) (2015) Rapport d’activité annuel
6.
go back to reference Bauer AW, Kirby WMM, Sherris JC, Turck M (1966) Antibiotic susceptibility testing by a standardized single disk method, Microbiol. Centen. Perspect. ASM Press, Washington, D.C., pp 40–45 Bauer AW, Kirby WMM, Sherris JC, Turck M (1966) Antibiotic susceptibility testing by a standardized single disk method, Microbiol. Centen. Perspect. ASM Press, Washington, D.C., pp 40–45
7.
go back to reference EUCAST European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters Version 7.1, valid from 2017-03-10 EUCAST European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters Version 7.1, valid from 2017-03-10
8.
go back to reference Johnson JR, Tiu FS, Stamm WE (1995) Direct antimicrobial susceptibility testing for acute urinary tract infections in women. J Clin Microbiol 33(9):2316–2323 Johnson JR, Tiu FS, Stamm WE (1995) Direct antimicrobial susceptibility testing for acute urinary tract infections in women. J Clin Microbiol 33(9):2316–2323
9.
go back to reference Klein Breteler KB, Rentenaar RJ, Verkaart G, Sturm PDJ (2011) Performance and clinical significance of direct antimicrobial susceptibility testing on urine from hospitalized patients. Scand J Infect Dis 43(10):771–776 Klein Breteler KB, Rentenaar RJ, Verkaart G, Sturm PDJ (2011) Performance and clinical significance of direct antimicrobial susceptibility testing on urine from hospitalized patients. Scand J Infect Dis 43(10):771–776
10.
go back to reference Zboromyrska Y et al (2016) Development of a new protocol for rapid bacterial identification and susceptibility testing directly from urine samples. Clin Microbiol Infect 22(6):561.e1–561.e6 Zboromyrska Y et al (2016) Development of a new protocol for rapid bacterial identification and susceptibility testing directly from urine samples. Clin Microbiol Infect 22(6):561.e1–561.e6
11.
go back to reference Gallah S, Decre D, Genel N, Arlet G (2014) The β-LACTA test for direct detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae in urine. J Clin Microbiol 52(10):3792–3794 Gallah S, Decre D, Genel N, Arlet G (2014) The β-LACTA test for direct detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae in urine. J Clin Microbiol 52(10):3792–3794
12.
go back to reference Amzalag J, Mizrahi A, Naouri D, Nguyen JC, Ganansia O, Le Monnier A (2016) Optimization of the β-LACTA test for the detection of extended-spectrum-β-lactamase-producing bacteria directly in urine samples. Infect Dis 48(9):695–698 Amzalag J, Mizrahi A, Naouri D, Nguyen JC, Ganansia O, Le Monnier A (2016) Optimization of the β-LACTA test for the detection of extended-spectrum-β-lactamase-producing bacteria directly in urine samples. Infect Dis 48(9):695–698
13.
go back to reference van den Bijllaardt W, Buiting AG, Mouton JW, Muller AE (2017) Shortening the incubation time for antimicrobial susceptibility testing by disk diffusion for Enterobacteriaceae: how short can it be and are the results accurate? Int J Antimicrob Agents van den Bijllaardt W, Buiting AG, Mouton JW, Muller AE (2017) Shortening the incubation time for antimicrobial susceptibility testing by disk diffusion for Enterobacteriaceae: how short can it be and are the results accurate? Int J Antimicrob Agents
14.
go back to reference Fröding I, Vondracek M, Giske CG (2016) Rapid EUCAST disc diffusion testing of MDR Escherichia coli and Klebsiella pneumoniae : inhibition zones for extended-spectrum cephalosporins can be reliably read after 6 h of incubation. J Antimicrob Chemother:dkw515 Fröding I, Vondracek M, Giske CG (2016) Rapid EUCAST disc diffusion testing of MDR Escherichia coli and Klebsiella pneumoniae : inhibition zones for extended-spectrum cephalosporins can be reliably read after 6 h of incubation. J Antimicrob Chemother:dkw515
15.
go back to reference Le Page S, Dubourg G, Rolain J-M (2016) Evaluation of the Scan ® 1200 as a rapid tool for reading antibiotic susceptibility testing by the disc diffusion technique. J Antimicrob Chemother 71(12):3424–3431 Le Page S, Dubourg G, Rolain J-M (2016) Evaluation of the Scan ® 1200 as a rapid tool for reading antibiotic susceptibility testing by the disc diffusion technique. J Antimicrob Chemother 71(12):3424–3431
16.
go back to reference Hombach M, Jetter M, Blöchliger N, Kolesnik-Goldmann N, Böttger EC (2017) Fully automated disc diffusion for rapid antibiotic susceptibility test results: a proof-of-principle study. J Antimicrob Chemother 72(6):1659–1668 Hombach M, Jetter M, Blöchliger N, Kolesnik-Goldmann N, Böttger EC (2017) Fully automated disc diffusion for rapid antibiotic susceptibility test results: a proof-of-principle study. J Antimicrob Chemother 72(6):1659–1668
17.
go back to reference Hombach M, Jetter M, Keller PM, Blöchliger N, Kolesnik-Goldmann N, Böttger EC (2017) Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6–8 h by automated disc diffusion antibiotic susceptibility testing. J Antimicrob Chemother 72(11):3063–3069 Hombach M, Jetter M, Keller PM, Blöchliger N, Kolesnik-Goldmann N, Böttger EC (2017) Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6–8 h by automated disc diffusion antibiotic susceptibility testing. J Antimicrob Chemother 72(11):3063–3069
19.
go back to reference Jorgensen JH, Ferraro MJ (2009) Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis 49(11):1749–1755 Jorgensen JH, Ferraro MJ (2009) Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis 49(11):1749–1755
20.
go back to reference Jorgensen JH (1993) Selection criteria for an antimicrobial susceptibility testing system. J Clin Microbiol 31(11):2841 Jorgensen JH (1993) Selection criteria for an antimicrobial susceptibility testing system. J Clin Microbiol 31(11):2841
Metadata
Title
Performance of rapid antimicrobial susceptibility testing by disk diffusion on MHR-SIR agar directly on urine specimens
Authors
Claire Périllaud-Dubois
Benoît Pilmis
Julien Diep
Gauthier Péan de Ponfilly
Simon Perreau
Louise Ruffier d’Epenoux
Assaf Mizrahi
Carine Couzigou
Barbara Vidal
Alban Le Monnier
Jean-Claude Nguyen Van
Publication date
01-01-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2019
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3413-5

Other articles of this Issue 1/2019

European Journal of Clinical Microbiology & Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.